Items without sitelinks
From determinar.ia.br - Determine suas informações
Showing below up to 50 results in range #5,651 to #5,700.
- Harmful effects of Angiotensin-converting-enzyme inhibitors (Q107164)
- Harmful effects of Oxytocic drugs (Q107163)
- Harmful effects of Aminophylline, theophylline (Q107162)
- Harmful effects of other anti-common-cold drugs (Q107161)
- Harmful effects of antitussives (Q107160)
- Harmful effects of other coronary vasodilators (Q107159)
- Harmful effects of anthelminthics (Q107158)
- Harmful effects of antimalarials or drugs acting on other blood protozoa (Q107157)
- Harmful effects of other antiprotozoal drugs (Q107156)
- Harmful effects of antimycobacterial drugs (Q107155)
- Harmful effects of other antihypertensive drugs (Q107154)
- Harmful effects of Sulfonamides (Q107153)
- Harmful effects of other drugs acting on muscles (Q107152)
- Harmful effects of expectorants (Q107151)
- Harmful effects of antiasthmatics, not elsewhere classified (Q107150)
- Harmful effects of Salbutamol (Q107149)
- Harmful effects of Terbutaline (Q107148)
- Harmful effects of unspecified drugs acting on muscles (Q107147)
- Harmful effects of antivaricose drugs, including sclerosing agents (Q107146)
- Harmful effects of antihyperlipidemic or antiarteriosclerotic drugs (Q107145)
- Harmful effects of peripheral vasodilators (Q107144)
- Harmful effects of Nitroglycerin, nitroglycerol, medicinal (Q107143)
- Harmful effects of skeletal muscle relaxants (Q107142)
- Harmful effects of calcium-channel blockers (Q107141)
- Harmful effects of other antidysrhythmic drugs (Q107140)
- Harmful effects of vancomycin (Q107139)
- Harmful effects of cardiac-stimulant glycosides or drugs of similar action (Q107138)
- Harmful effects of sodium fusidate (Q107137)
- Harmful effects of fusidic acid (Q107136)
- Harmful effects of tetracyclines (Q107135)
- Harmful effects of co-trimoxazole (Q107134)
- Harmful effects of rifampicin (Q107133)
- Harmful effects of antifungal antibiotics, systemically used (Q107132)
- Harmful effects of macrolides (Q107131)
- Harmful effects of other hormone antagonists (Q107130)
- Harmful effects of aminoglycosides (Q107129)
- Harmful effects of trilostane (Q107128)
- Harmful effects of chloramphenicol group (Q107127)
- Harmful effects of cephalosporins and other beta-lactam antibiotics (Q107126)
- Harmful effects of Penicillins (Q107125)
- Harmful effects of unspecified hormone antagonists (Q107124)
- Harmful effects of anterior pituitary hormones (Q107123)
- Harmful effects of other hormones or synthetic substitutes (Q107122)
- Harmful effects of androgens or anabolic congeners (Q107121)
- Harmful effects of unspecified hormones or synthetic substitutes (Q107120)
- Harmful effects of antigonadotropins, antiestrogens, antiandrogens, not elsewhere classified (Q107119)
- Harmful effects of oral contraceptives (Q107118)
- Harmful effects of Glucocorticoids or synthetic analogues (Q107117)
- Harmful effects of Camphor (Q107116)
- Harmful effects of other estrogens or progestogens (Q107115)
